Heather Tablet
Product Images NDC 68462-303

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Heather (NDC 68462-303). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Glenmark Pharmaceuticals Inc., Usa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure Of Norethindrone

Chemical structure of norethindrone, depicting its steroid framework with functional groups attached, consistent with the active ingredient in HEATHER tablets.*

FDA Label Image

Carton (Carton)

Packaging label for HEATHER (Norethindrone) Tablets, USP 0.35 mg, oral tablets by Glenmark Pharmaceuticals Inc., USA. The label shows the product name, strength, dosage form, and manufacturer. It indicates the package contains 3 blisters, each with 28 tablets, and is labeled for Rx only. Storage instructions and a barcode are also visible.*

FDA Label Image

Day Label Sticker Placement Graphic

An instructional diagram showing a hand placing a peel-and-stick day label onto a 28-day blister card for Norethindrone tablets, USP 0.35 mg. The card is divided into four weeks, with days labeled Sunday through Saturday. The diagram demonstrates how to align the correct day label for organized daily scheduling of oral tablet doses.*

FDA Label Image

Figure1

A pharmacokinetic curve showing the plasma concentration (Cp in pg/mL) of Norethindrone over time (hours) following a 0.35 mg oral dose. The graph illustrates a rapid increase in concentration, peaking early, followed by a decline approaching near zero levels by 48 hours.*

FDA Label Image

Glenmark Log

FDA Label Image

Glenmark Logo

FDA Label Image

Pouch (Pouch)

Label for HEATHER (Norethindrone) Tablets USP 0.35 mg, oral tablet prescription drug by Glenmark Pharmaceuticals Inc., USA. The packaging contains 1 blister of 28 tablets. Directions emphasize storage instructions, dosage, and patient instruction importance. The product is identified by NDC 68462-303-84.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.